Cellular Biomedicine Group Announces $30.6M Investment From Sailing Capital Overseas Investment Life Science
Cardinal Health Announces Closing of Cardinal Health China Distribution Business Divestiture to Shanghai Pharma Life Science
Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize NERLYNX (neratinib) in Greater China Life Science
Over 100 Chinese Internet Companies Go Public in 2017 With Total Market Value of USD1.4 Trillion Technology
China Oncology Focus Limited Receives Approval by Chinese Authorities to Begin Clinical Trials in Three Separate Cancer Indications Using Sorrento’s Anti-PD-L1 Monoclonal Antibody Life Science